MUDr. Ondřej Bílek, Ph.D.
Assistant professor, Comprehensive Cancer Care Department
correspondence Address:
Žlutý kopec 534/7, 656 53 Brno
e‑mail: | 60272@mail.muni.cz |
---|
Total number of publications: 25
2024
-
Aktuální klinické charakteristiky a léčebné postupy karcinomu plic v onkologickém centru v České republice z reálné praxe - data z registru Masarykova onkologického ústavu z let 2018-2022
Klinická onkologie, year: 2024, volume: 39, edition: 6, DOI
-
Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic - data from Masaryk Memorial Cancer Institute registry in 2018-2022
Klinická onkologie, year: 2024, volume: 37, edition: 6, DOI
-
Diagnosticko-terapeutický management plicních nodulů
Klinická onkologie, year: 2024, volume: 37, edition: 6, DOI
-
Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer
BMC Cancer, year: 2024, volume: 24, edition: December, DOI
-
Péče o pacienty po ukončení kurativní onkologické léčby, kapitola Plicní chronické a pozdní nežádoucí účinky onkologické léčby
Péče o pacienty po ukončení kurativní onkologické léčby, year: 2024, number of pages: 9 s.
2023
-
Lung Cancer in the Czech Republic
Year: 2023, type: Article in Periodical (without peer review)
2022
-
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
Diagnostics, year: 2022, volume: 12, edition: 7, DOI
2021
-
Drug interaction profile of TKI alectinib allows effective and safe treatment of ALK plus lung cancer in the kidney transplant recipient
International Immunopharmacology, year: 2021, volume: 99, edition: October 2021, DOI
-
Immunotherapy in the treatment of non-small cell lung cancer.
Klinická onkologie, year: 2021, edition: 34(Supplementum 1), DOI
-
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence
Cancers, year: 2021, volume: 13, edition: 7, DOI